Cannabis and Schizophrenia, Cure or Cause?

Growing up you may have heard about the guy in the neighbourhood who hears voices in his head. And you also know that his disease — schizophrenia (according to DARE, anyways) was probably the result of the innumerable joints he used to take as a youngster. Well, one section of medical scientists has dared to […]

The post Cannabis and Schizophrenia, Cure or Cause? appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

Webinar Replay – Building a Cannabis Business in New York: An Operator’s Perspective

For anyone who was unable to join our September 23rd webinar, Building a Cannabis Business in New York: An Operator’s Perspective, we’ve got you covered! Below, please find the full presentation for your viewing pleasure.

You can download the transcript HERE.

Stay up to date on cannabis in New York via the Canna Law Blog.


Cannabis Litigation: What You Need to Know

Tuesday, October 19th at 2pm EDT/ 11am PDT



The post Webinar Replay – Building a Cannabis Business in New York: An Operator’s Perspective appeared first on Harris Bricken.

We tried it: Kanha Sour Cherry Belts review

You’d be hard-pressed to find a gummy shortage in any corner of the edibles market. Most edible companies use THC or CBD distillate to infuse their gummies, and typically separate them into 10-milligram pieces. “All of the bright packages and kaleidoscope of flavors could lead you to believe that infused candy possibilities are endless,” wrote Kate Ryan for Weedmaps. “But as a gummy connoisseur, let me tell you: most weed gummies are virtually indistinguishable.”

In a market where most weed gummies are nearly identical on a chemical level, the search for a canna-infused chewable treat that separates itself from the pack ultimately becomes a matter of presentation, form, flavor, and personal taste. If there’s a major difference in how a gummy makes you feel, it’ll depend on whether the gummy includes other cannabinoids and terpenes (even in trace amounts), as well as one’s own genetic predisposition to absorb cannabinoids through digestion. 

As someone who’s tried just about every popular gummy in Southern California, and whose body is generally receptive to edibles, Kanha’s infused gummy belts hit a sweet spot for me between familiarity and innovation in both presentation and effect. 

For this review, I’ll be taking a look at Kanha’s new Sour Cherry Limeade infused belts. 

First impressions

Kanha belts come in your typical, heavy-duty resealable bag with all the usual information displayed on the front label, including quantity (two belts), THC content (50 milligrams THC per belt, with five 10-milligram servings per belt), and flavor (emphasizing sour to distinguish it from Kanha’s regular, sweeter belt line).

One standout element of the label, however, is a white line near the bottom containing bold, black, capital-letter print that reads “for the high-dose consumer.” This product’s relatively subtle but distinct framing distinguishes it from your typical 10-milligram gummy. Though the label also indicates that the product can be eaten in moderate-dose, 10-milligram segments, designating it as a 50-milligram total, high-dose product is a significant sea-change.  

On the back of the package, there’s a section that elaborates on the “high-dose consumer” angle, suggesting dosing flexibility that retains the consumer who prefers moderate, controlled doses without ditching the advertised high-dose functionality altogether. 

Again, most of this is a matter of presentation. And sure, one could just as easily buy a tin of 10-milligram gummies and take five of them at once to theoretically get the same effect. There are also plenty of chocolate bars and other edibles that are one high-dose piece theoretically divided into 10- or 5-milligram segments. Still, the fact that this gummy product guides consumers to make their own choice about dosing with flexibly high-dose parameters makes it a significant and worthwhile outlier.


When I opened up my bag of Kanha Sour belts, I was a bit taken aback by the heft and texture of them. Other gummy “belts” I’ve tried have been ultra-thin and, frankly, not particularly tantalizing in terms of texture or taste. These belts have a delightfully sweet flavor, while the sourness is more of a subtle accent. 

Overall, these belts offer a consumption experience that’s significantly more enjoyable than competing products I’ve tried.


In light of the product’s “high-dose consumer” designation, I decided to test out its effectiveness by breaking off three segments for a total of 30 milligrams of THC. This would give me an idea of how effective the product is in high doses while still being a little cautious for my first run. I figured taking a dose between 10 and 50 milligrams would also give me some idea of what to expect on either end of the spectrum.

I broke off three segments of one belt and ate them at about 6 p.m., about an hour before dinner. I should mention that I was particularly impressed with how easily breakable the belt segments are, though as a whole piece, the belt felt and looked very much like one seamless gummy treat. Anyway, an hour passed, almost to the minute, before I felt the effects kick in, subtle and creeping at first, then all at once, like a slow-mo mad psychedelic rush of blood to the head.


That hour between consumption and activation was one of those between hours where you kind of forget you took an edible because you’re just lost enough in the mundanity of now or whatever else is going on. My wife had just got home and we were engaging in our typical “how was your day” decompress session. As the hour passed and I found myself in that, “oh yeah, am I feeling this yet?” phase of the creep-up, my wife was in the middle of telling me this spooky real-life ghost story she’d heard from someone at work. Then the universe timed it just right so the climax to her story hit right when I got that bang-boom-pow “oh yeah, I AM feeling this” feeling. But a bad trip this wasn’t. When it hit, it hit hard, but not alarmingly or anxiously, as frequently happens with high-powered edibles.

The rest of the night played out like one long chill-beat jazz hop playlist, the type of high that slowed down time enough for me to scarf down a good meal but still feel like I was savoring it. After dinner, I streamed a couple of shows and found myself enjoying them and (mostly) following them even as my mind raced with thoughts and impressions and multiple threads of ideas. 

It was a bit of a rapid-fire mind trip, but one I enjoyed and felt in sync with. And through it all, I felt my limbs loosen and warm up with high-potency tingles. At some point, I was worried I’d start to get the shivers, which is always my first sign of an edible high about to go bad, but the shivers never came, and neither did my usual bout with mild paranoia. 

By the time I thought about looking at my watch it was a quarter to 10:00. I was still high, but had been on the downslope for roughly a half-hour. That’s when my body sank further into heavy relaxation, the mind haze started to lift, and my eyesight became sharper again.

Bottom line

An edible — or any high-potency weed product — hits right for me when I feel in sync with the chaos of all possible sensory input l both lost and found on a perpetual free-fall dive through the great void that contains everything. 

Thirty milligrams of Kanha’s Sour Cherry Limeade candy belt put me in that exact space for sure, curbing anxiety and paranoia while relaxing the body and totally flipping the dial on all head-buzz frequencies. Plus, it’s a tasty treat presented in a fluid, consumer-friendly form. 

So if you’re a high-dose consumer, this is a gummy worth seeking out and conveniently trying at your own pace. 

Featured image courtesy of Kanha/Weedmaps

The post We tried it: Kanha Sour Cherry Belts review appeared first on Weedmaps News.

Mississippi Lawmakers Move to Implement Medical Cannabis Legislation

After months of negotiating, lawmakers in Mississippi reached a deal this week to implement a new medical marijuana law in the state.

Mississippi Today reported that “legislative negotiators and leaders have agreed on a draft of medical marijuana legislation,” and that they are “anticipated to ask Governor Tate Reeves as early as Friday to call the Legislature into special session.”

The approach to Reeves could be significant, as the report noted that the first term Republican governor “has sole authority to call lawmakers into special session, and would set the date and parameters of a special session.”

“Although legislative leaders have expressed interest in dealing with COVID-19 and other issues in a special session, Reeves has appeared unwilling but said he would call a session for medical marijuana, pending lawmakers are in agreement and he agrees with the measure,” the report said. 

In May, Reeves said that a special session to address medical marijuana was “certainly a possibility.” 

For medical cannabis advocates and would-be patients of the treatment, the legislative wrangling has been a long, and at times frustrating, process.

Nearly 70 percent of Mississippi voters approved a ballot initiative last year that legalized medical marijuana for a host of qualifying conditions including cancer, epilepsy or other seizures, Parkinson’s disease, Huntington’s disease, muscular dystrophy, multiple sclerosis, cachexia (weakness and wasting due to chronic illness), post-traumatic stress disorder, HIV+, AIDS, chronic or debilitating pain, amyotrophic lateral sclerosis, or ALS, glaucoma, agitation from dementia, Crohn’s disease, ulcerative colitis, sickle-cell anemia and autism. 

Under Initiative 65, qualifying patients could legally possess up to 2.5 ounces of cannabis.

But the new law hit a major snag in May, when the state’s Supreme Court struck down Initiative 65 citing a strange and obscure provision in the state’s constitution. In the 6-3 ruling, the majority justices “ held the initiative had to be struck down because of an odd flaw in the state constitution’s voter initiative process,” NBC News reported at the time. 

“Passed in the 1990s, the measure called for a percentage of signatures to come from each of the state’s five congressional districts to get on the ballot,” NBC reported. “But, the judges noted, the state lost one of those congressional districts thanks to the 2000 U.S. Census, and now only has four districts.”

After that ruling, lawmakers in Mississippi went back to the drawing board to create a new medical marijuana program to supplant Initiative 65. 

Negotiations ran through the summer, with state lawmakers and other agencies hearing testimony from both advocates and opponents to medical cannabis. 

The breakthrough finally arrived on Thursday. Mississippi Today reported that some legislative leaders “released some details of the proposal—which had been kept close to the vest for months—such as that cities and counties will be allowed to ‘opt out’ of having medical marijuana cultivation or dispensaries, although local voters can override this.”

“City councils or aldermen, or county boards of supervisors, within 90 days of passage of legislation, could opt out from allowing cultivation or dispensing of medical marijuana within their borders,” the report explained. Voters in those cities and counties could force a referendum to rejoin the medical marijuana program if they gathered 1,500 signatures or 20 percent of the voters, according to the report.

Other notable provisions in the draft proposal include that smokable cannabis would be permitted, and that the state’s sales tax of seven percent would be imposed on medical marijuana. But the lawmakers have closed the door on personal cultivation, with Mississippi Today reporting that “outdoor growing would not be allowed, nor home growing.”

The post Mississippi Lawmakers Move to Implement Medical Cannabis Legislation appeared first on High Times.

Felons Can Now Get Cannabis Licenses in Washington State

Felons will no longer be automatically barred from getting a cannabis license in Washington State, beginning next Saturday on October 2. Several updates to the rule now allow some people with serious felonies to obtain cannabis licenses, on a case-by-case basis.

That’s thanks to a new rule set by the Washington State Liquor and Cannabis Board that will go into effect shortly. Anyone who obtains a license must first pass an obligatory background check, but now, a felony on a record won’t necessarily be an automatic disqualifier.

Serious felony convictions within the past 10 years, however, will still trigger deeper scrutiny of a person’s application. But the rules no longer bar people with felonies from receiving a license. 

The protocol for less serious felonies also was updated. Specifically, one Class C felony on a record won’t automatically bar their license application. In addition, if someone has fewer than three misdemeanor convictions in the past three years, that won’t be enough to prompt a deeper review. 

Failure to report an old misdemeanor from juvenile court won’t count against applicants anymore, either.

With a strong focus on social equity in recent years, the rule change is being celebrated by cannabis business people because it allows people who were arrested at disproportionate rates to enter the legal industry.

“I think it’s great what the state is doing in terms of allowing people who have issues in the past, to be able to qualify,” Tran Du, co-owner of Shawn Kemp’s Cannabis in Seattle, told KOMO News.

The idea behind the rule change is that people who were arrested at disproportionate rates for cannabis shouldn’t be barred from participating in the industry, now that it’s legal.

“We wanted to bring parity in the disproportionality that we saw from the leftover of the war on drugs and that Black people were being arrested and brown people were being arrested disproportionately,” said Representative Melanie Morgan (D-Parkland) who is also chair of the state Social Equity on Cannabis Task Force.

Morgan stressed the need to get the state’s priorities in line. “The bottom line is bringing parity to the industry and making sure that Black and brown people have equal access to this industry in ownership,” she said.

Why Allow Felons?

Disparities in arrest rates of people of color are evident in numerous states, and Washington state is no different.

A study conducted by the Marijuana Arrest Research Project, entitled “240,000 Marijuana Arrests Costs, Consequences, and Racial Disparities of Possession Arrests in Washington, 1986‐2010,” found that although African Americans and Latinx people consume marijuana at lower rates than whites, African Americans were arrested for marijuana crimes at 2.9 times the rate of whites in the state. Latinos were arrested at 1.6 times the rate of whites.

The burden of a felony can prevent some people from participating in the cannabis industry. As an example, High Times highlighted the case of Katree Darriel Saunders, who was barred from Nevada’s industry over a pot charge. As a one-time employee in the Nevada medical space, served four months in federal prison over a probation violation after choosing cannabis over opioids to treat trauma and injuries. That choice has burdened Saunders for over a decade, largely preventing her from participating in the industry despite years of experience, success and an otherwise spotless record. 

Other routes into the cannabis industry are available, depending on what state you live in. Several states that have legalized marijuana also offer opportunities for convicts to expunge their records.

The post Felons Can Now Get Cannabis Licenses in Washington State appeared first on High Times.

China and Cannabis: Stigmatization and Continued Crackdown

Cannabis in China remains a complicated issue. Cannabis faces stigmatization, and the Chinese government continues to crack down on usage. The Chinese government’s attempts to stamp out perceived social ills are nothing new. Just recently, the government implemented new policies that restrict gaming time for youths. Policies around cannabis are similarly strict, so let’s start […]

The post China and Cannabis: Stigmatization and Continued Crackdown appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

City of Denver Releases Annual Report on Local Cannabis Industry

Officials in the city of Denver released its annual cannabis industry report, which covers a wealth of information about most recent data and its comparison to previous years.

A report called “The Denver Collaborative Approach,” conducted by the city of Denver, Colorado, was released on September 20. This report has been consistently published every year since 2015, one year after recreational legalization was implemented. The report covers a wide variety of industry facts and figures, including cannabis taxes, sales and revenue, noteworthy accomplishments and more.

“As legalization spreads across the United States, Denver remains squarely in focus. More than ever, the city is looked at to provide guidance on how it effectively implemented and continues to manage the first-of-its-kind sales and commercialization of voter-approved retail marijuana,” the report states in its introduction. 

It continues to recap the fluid efforts of the Denver Office of Marijuana Policy and how it is constantly at work to ensure that the city’s cannabis industry remains compliant. “Denver continues its collaborative approach to marijuana management, remaining nimble and flexible to keep pace with the sustained growth of sales and innovation in the marijuana industry, while remaining in constant communication with the industry and residents to ensure balance among many competing interests.”

In January 2014, Denver was home to 731 medical cannabis business licenses and 270 retail licenses. As of January 2021, the number of licenses is much more balanced, sitting at 441 and 476 respectively (although January 2020 showed similar results).

The report’s sales data only reflects sales that were collected in 2020. Between 2019 and 2020, recreational cannabis sales increased by 18 percent, and medical cannabis sales increased by 31 percent. For the entirety of the state of Colorado during the same timeframe, recreational cannabis sales increased by 25 percent, with medical sales expanding at a rate of 31 percent.

Unsurprisingly, 32.6 percent of the state’s recreational cannabis sales came from the city and county of Denver. This exhibits a consistent decrease in sales from Denver, which suggests that cities outside of Denver have continued to grow and expand. As a whole, combined Colorado retail and medical cannabis sales is recorded at $715 million during 2020 (a 21 percent increase from 2019).

So far in 2021, $24.6 million of the city’s cannabis revenue was granted toward “affordable housing and homelessness services, youth violence prevention, STAR program pilot implementation, leases and other one-time equipment costs.”

The report spotlights some of the city’s accomplishments between 2014-2020, which includes donating money toward various community services, such as free after-school and summer programs for children and the establishment of a recreation center in 2018. The report also notes what other changes it seeks to implement. First, the city intends to examine how it can further assist local cannabis businesses on a financial, technical and business support level. It also aims to “provide social equity applicants licensing exclusivity for most licenses for the next six years and the exclusive ability to conduct deliveries for the next three years.” 

Second, it wants to continue a focus on clearing cannabis-related convictions with its Turn Over a New Leaf Program, which was first put into effect in 2019. So far, the program has received 583 applications, and 94 convictions were labeled as “eligible” for expungement.

“Under the leadership of Mayor Hancock, the city has adopted a collaborative model to manage marijuana, which includes multiple agencies working together to preserve, protect and enhance Denver’s excellent quality of life. This work is grounded in the city’s priorities of marijuana management, including robust regulation, strict enforcement, effective education and equitable access to the industry.”

The report’s last section goes into great detail about the city’s law enforcement data, including details about black market sales and common offenses. The Denver Police Department collected 3,098 pounds of illegal cannabis in 2020. Local police report that cannabis-related offenses account for less than one percent of all crime in the city of Denver, with a total of 435 in 2020 (out of the city’s total offenses across the board, which sits at 73,322).

“The Denver Collaborative Approach” report is a valuable source of information regarding the city’s cannabis industry, and it’s a positive example of a city embracing all aspects of cannabis within its borders.

The post City of Denver Releases Annual Report on Local Cannabis Industry appeared first on High Times.

Don’t Get too Hyped on California’s New Hemp Law Just Yet

Last week, AB-45 completed its run through the California legislature and was presented to Governor Gavin Newsom for his signature, which is probably imminent. Once he signs it, the law takes effect and will pave the way for legal CBD consumables, while banning (at least temporarily) any kind of hemp-derived inhalable product. If you want to read our prior analysis of AB-45, see this post.

If you know even a little about the twists and turns of California’s attempts to legalize CBD since 2018, you’ll appreciate just how monumental this bill is, at least in theory. In 2019, AB-228 made it almost to the finish line but stalled out due to opposition (see my posts hereherehere, and here). In 2020, California legislators tried (and failed) to do the same thing two times with AB-2827 and AB-2028. Personally, I was telling people all year that even AB-45 didn’t stand a great chance.

Now that AB-45 has passed, a lot of folks are celebrating while others (namely inhalable product stakeholders) are upset. All of these reactions may be premature because things are likely to change substantially over the coming months (assuming Newsom signs AB-45) when the California Department of Public Health (CDPH) issues CBD regulations.

Before getting into these regs, it’s important to highlight that CDPH hates CBD. In 2018, and without any law supporting them or going through any kind of official rulemaking process, CDPH took it upon itself to straight up ban CBD foods and beverages in the state via a website FAQ. You can read an older analysis of mine on the CDPH’s position here. And at the beginning of this year, CDPH expanded its position to cover topical products via a revised FAQ.

With that all in mind, here are some of the things that CDPH has the power to or will have to regulate under AB-45:

  • Good manufacturing practice standards for manufacturers;
  • The amount of THC that’s allowed to be present raw hemp extract not intended for human consumption (i.e., work-in-process hemp extract);
  • Minimum age requirements for hemp products on a finding of emergency;
  • Prohibition of human or animal products that CDPH deems harmful;
  • Serving sizes;
  • Record-keeping standards;
  • THC concentration and ratio of cannabinoids for final-form products;
  • Specific contaminant levels (as an aside, the contaminant-level standards for California cannabis products are basically ported into the hemp market through AB-45, and CDPH is free to add even more standards);
  • Basically anything else within the purview of AB-45, including things like labeling, licensing fees, etc.

I have worked on hundreds of matters dealing with CDPH cannabis issues and CBD issues in California prior to AB-45. I have seen (a) how intensely CDPH regulated cannabis, and (b) how aggressively they went after CBD for reasons that still remain very unclear to me.

I can only surmise that when — not if — CDPH issues CBD regulations, they will be extremely aggressive and basically box out anyone in the industry who does not have the resources to spend tens of thousands of dollars or more on compliance. I firmly believe that the “wild west” days here are coming to an end and businesses that want to get into the California CBD industry are going to need to muster up some serious cash and focus on compliance rather than just marketing. I could be wrong, but I don’t think so.

Keep in mind too that the initial set of regulations will be exempt from the state Administrative Procedure Act and will be considered “emergency” regulations, which will take effect immediately while the public is commenting on them. CDPH could drop regulations at any time, and if it does there will probably be an initial period of chaos where people try to mold their existing CBD businesses into compliant ones. That too will be expensive.

Don’t get me wrong, on balance I am happy AB-45 passed and that the state will not take an arbitrary and (in my opinion, stupid) position on CBD anymore. But we all need to be very weary about what the future holds, and prepared to do a lot of work.

The post Don’t Get too Hyped on California’s New Hemp Law Just Yet appeared first on Harris Bricken.

U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote

The U.S. House approved the Secure and Fair Enforcement (SAFE) Banking Act on Thursday in a bipartisan 316-113 vote as part of the latest National Defense Authorization Act, a military spending bill. It’s the fifth time the legislation has been approved in the House as a standalone bill or an amendment as part of larger legislation.

Since statewide cannabis reform has been enacted over the past four decades, cannabis businesses still are not fully tolerated, most evidently in federal restrictions, such as the way banking is restricted.

Representative Ed Perlmutter re-introduced the bill, as promised, saying that it would allow cannabis businesses to access the banking system—like any other industry—and would bring more money into the economy and offer the opportunity to create good-paying jobs. 

On September 21, the House Rules Committee approved the SAFE Banking Act as they sifted through over 800 amendments filed for the $778 billion FY2022 National Defense Authorization Act (NDAA) to determine which ones will get a floor vote. As Representative Perlmutter sits in the Rules Committee, the move suggests he has influence.

Currently, The Financial Crimes Enforcement Network (FinCEN) Guidance from the Department of the Treasury provides informal guidance on banking with cannabis businesses, but still nothing to immunize a financial institution from federal prosecution—only an act of Congress can do that.

Bloomberg reported that the SAFE Banking Act would be a boon for cannabis companies—which up until now have been forced to do business in cash thanks to federal banking restrictions. Cannabis-adjacent companies that provide financial services agreed.

“Passage of the SAFE Banking Act is a historic, significant step forward for the cannabis industry, which deserves more legitimacy and access to banking, insurance and other services just like any other mainstream industry. This legislation will open up much-needed access to financial institutions and loans for cannabis industry entrepreneurs,” said Ryan Hale, Chief Sales Officer of Operational Security Solutions (OSS). “Meanwhile, as the sheep dogs for the industry in security, we know that many compliance issues will remain as long as cannabis is still considered a Schedule I drug and passage of the SAFE Banking Act will only mean more regulation for the industry.”

The bill would protect banks that cater to state-licensed cannabis business from facing punishment from federal regulators. As of December 2020, the U.S. Treasury found that 515 banks and 169 credit unions already provide such services.

NORML sent leaders in Congress a letter in support of its inclusion as part of the NDAA. NORML Political Director Justin Strekal applauded the legislation cautiously:

“It is critical to balance the need to accomplish comprehensive reform at the federal level and make every effort possible in the immediate term to support the successful state-level programs to ensure safe and efficient consumer access to quality cannabis that is cost-competitive with the unregulated market,” Strekal said. “For those reasons, we support the inclusion of the SAFE Banking Act in any piece of legislation that is going to be enacted into law.”

Advocates speculated that the SAFE Banking Act might have a better chance of success than a standalone bill, because of its bipartisan support and because Senators don’t want any minor bill holding up the “must-pass” NDAA.

Leaders such as Senate Majority Leader Chuck Schumer and Senator Cory Booker have been somewhat hesitant to support the bill without seeking broader reform. Both see more comprehensive cannabis reform such as the Cannabis Administration and Opportunity Act (CAOA).

“As someone who has been working inside the banking industry for most of my career, I’ve seen firsthand the many challenges banks face when trying to serve cannabis businesses,” said Andrew Montgomery, Founder and CEO of HD Compliance. Montgomery is a seasoned banking professional with more than 25 years as a senior executive in the industry. 

He continued, “Though this is not the first time that lawmakers have added a seemingly unrelated bill to a broader bill that is likely to pass without increased scrutiny, we must remember that the SAFE Banking Act has already been passed four times in the House, two of them were associated with COVID-19 economic relief bills. The Senate failed to act on each of those bills. However, burying it in the Defense Authorization Act may give cover to GOP senators that want to support SAFE Banking and allow Senator Cory Booker to oppose the bill. This very well could be a back door way of passing this needed legislation.”

While some leaders argued about the appropriateness of including the SAFE Banking Act in a military spending bill, veteran support for cannabis is high. NORML, for instance, clarified that the spending bill was indeed an “appropriate vehicle” for cannabis reform. According to the American Legion, nearly one in four veterans currently consumes cannabis for medical reasons.

The post U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote appeared first on High Times.

8 of the best strains for focus

It’s 12:47 p.m. and you’ve got a whole heap of work that you’ve been avoiding. You know none of the tasks are too hard, but for some reason, you just can’t sit still and concentrate for long enough to do them. Still, sunlight is ticking, stress is mounting, and you know you’ll feel like hot garbage if you end the day with nothing to show for your time. You think, “All I need to do is smoke a little weed and I can zone in.” 

Which strains are you picking?

There are plenty of cannabis strains that can help you focus. And with so many constant distractions in the world, I wouldn’t blame you for wanting to try them all. While I could never name every single one, here are eight that might help you block out the noise for long enough to get shit done.

White Fire OG

White Fire OG, also called WiFi OG, is a cross of Fire OG and The White. The nugs are light green and frosty with trichomes, and the smoke tastes like gassy pine needles — which is perfect for anyone that loves chemmy diesel flavors. On the high side,  WiFi OG is great for people whose thoughts are always moving at 744 mph. It’s potent yet manageable high can help clear your mind of anything that’s not immediately in front of you.

Lemon Thai

Most strains with Thai genetics are good for a clear-headed high that can help you defeat procrastination. Lemon Thai is no different. A cross of a Thai landrace and a Hawaiian sativa, this citrusy strain is great for anyone who’s been caught with that middle-of-the-day lag that makes even simple tasks feel the most daunting. If you’re the type of consumer that likes to puff on a vape pen throughout the day, Lemon Thai is a great cart to have handy.

Jack Frost

When you’re talking strains that help you focus, it’s only right that we bring Jack to the table. A cross of the famed Jack Herer, Northern Lights #5, and White Widow, Jack Frost is for those who need to get dumb stoned to focus. It hits you with a potent high that’ll have you knocking out the day’s to-do list without issue. Like most strains with Jack genetics, it usually has a citrusy and earthy aroma, however some people report that it may also have a somewhat fruity smell to it.

Dutch Treat

Believed to be a cross of Northern Lights and Haze genetics, Dutch Treat pushes out strong piney terpenes that alert your senses in the same way walking through the forest on a hike does. 

The delicious flavor is followed by a potent, clear-headed cerebral stimulation that many describe as the “hybrid high.” Old school and tasty, , Dutch Treat is a perfect suggestion for the dabbers.


As your cannabis knowledge bag gets deeper, you’ll learn that not every desired effect comes from THC. There are plenty of CBD strains out there that can help you focus too. 

Canna-Tsu is a CBD-dominant cross of Cannatonic and Sour Tsunami. It has sweet, earthy flavors, and the effect is relaxing in the body. I get a little anxious sometimes, and anything with Cannatonic genetics usually chills me out in a way that smoking too much THC doesn’t. If you’re looking for something light and manageable, this (or either of its parents), are solid options.

Jah Goo

A lot of times, being able to focus isn’t about energizing yourself or clearing out your mind, it’s about relaxing your body. Jah Goo is a great strain for doing just that.

This cross of Goo and Purple Jasmine produces colorful flowers with purple hues and pink hairs, and a somewhat sweet and woody flavor. The strain’s stoney high may be a little much for inexperienced consumers, but the vets may find it just right for that 10 am smoke before flipping the Go switch.

Bay Dream

If you love Granddaddy Purple then you might love Bay Dream too — it comes from the same breeders. Bay Dream, or GDP Bay Dream, is a cross of the beloved Blue Dream and a Bay 11 hybrid. Like Blue Dream, it has a sweet flavor profile, but also features woody and piney attributes. The cerebral high provides a nice, long-lasting euphoria that helps people get active for everything that needs to get done before 5 p.m.


Harle-Tsu is another CBD strain for consumers that don’t want to get high, but still want the benefits that come with smoking weed. As its name suggests, it is a cross of Harlequin and Sour Tsunami, two of the most well-known CBD flowers. If you’re here for taste, look elsewhere, as Harle-Tsu is pretty earthy and bland; but if you’re here for effects, this strain usually makes people feel relaxed in the body and focused in the mind.

Find thousands of strains on Weedmaps

Featured image by Gina Coleman/Weedmaps

The post 8 of the best strains for focus appeared first on Weedmaps News.